Can expression of CD95 (Fas/APO-1) ligand on grafts or tumor cells prevent their rejection?
- Author(s)
- Allison, J; Seino, K; Yagita, H;
- Details
- Publication Year 1998,Volume 19,Issue #3,Page 311-322
- Journal Title
- SPRINGER SEMINARS IN IMMUNOPATHOLOGY
- Publication Type
- Journal Article
- Publisher
- SPRINGER VERLAG
- Keywords
- FAS LIGAND; IMMUNE PRIVILEGE; MONOCLONAL-ANTIBODY; NECROSIS-FACTOR; IL-8 SECRETION; IN-VIVO; APOPTOSIS; MICE; LYMPHOCYTES; INDUCTION
- Publisher's Version
- https://doi.org/10.1007/BF00787228
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 1998-01-01 12:00:00